Urolithin A
Educational information only — not medical advice. Many listed compounds are not FDA-approved for human use. Consult a licensed clinician before starting, changing, or stopping any protocol.
Overview
Urolithin A is a postbiotic — a metabolite produced by your gut bacteria from dietary ellagitannins found in pomegranates, walnuts, berries, and similar foods. Unlike a peptide or directly consumed nutrient, urolithin A is manufactured in the colon by specific microbial species. It is studied primarily for its role in promoting mitophagy, the recycling of damaged mitochondria, which may support cellular energy and muscle performance.
Most research to date is based on animal models and emerging human clinical trials. The evidence in humans is promising but still early-stage, with the largest published trial conducted over 4 months. Urolithin A is marketed as a dietary supplement and is not approved by the FDA as a therapeutic drug, though the branded form (Mitopure) has received FDA GRAS status.
How it works
Urolithin A activates cellular pathways that trigger mitophagy — the process by which cells identify and remove dysfunctional mitochondria, then synthesize new ones. This renewal cycle appears to improve mitochondrial efficiency and energy output. In human studies, supplementation with urolithin A also correlated with lower levels of inflammatory markers and improved profiles of amino acid metabolism, suggesting systemic metabolic benefits.
The precise mechanisms in human physiology are not fully characterized, but the evidence points to urolithin A acting as a signaling molecule that enhances mitochondrial biogenesis and cellular energy capacity.
Reported benefits
- Increased muscle strength and muscular endurance (human trial data)
- Improved aerobic capacity and exercise performance
- Enhanced mitochondrial gene expression and metabolic efficiency
- Reduced systemic inflammation
These are reported findings from clinical studies, not guaranteed outcomes, and individual responses may vary.
Considerations & side effects
Because urolithin A research in humans is relatively recent, long-term safety data is limited. Short-term trials of up to 4 months have reported an excellent safety profile with minimal adverse effects. Some individuals may experience mild gastrointestinal effects.
The gut-microbiome requirement means not everyone who consumes ellagitannin-rich foods will produce adequate urolithin A endogenously. Supplementation bypasses this limitation. Product quality and purity can vary; reputable manufacturers conduct third-party testing. Urolithin A is not a substitute for medical evaluation or treatment by a qualified healthcare provider.
Frequently asked
What is Urolithin A?
A postbiotic compound produced by specific gut bacteria when they metabolize ellagitannins found in foods like pomegranates, walnuts, and berries. Unlike peptides or nutrients you consume directly, urolithin A is made in your colon by your microbiome.
Is Urolithin A FDA-approved?
Urolithin A is not FDA-approved as a drug. It is sold as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA). The branded form, Mitopure, achieved FDA GRAS (Generally Recognized as Safe) status in 2020.
How does Urolithin A work?
Urolithin A activates mitophagy — a cellular recycling process that clears damaged mitochondria and promotes the formation of new, healthy ones. This improved mitochondrial turnover is thought to enhance energy production and endurance.
Can I get Urolithin A naturally from food?
Only indirectly. Eating ellagitannin-rich foods (pomegranate, raspberries, walnuts) provides the raw material, but your gut bacteria must convert them to urolithin A. Not everyone produces it efficiently — approximately 1 in 3 people generate meaningful amounts.
What does the research show?
Randomized human trials have observed improvements in muscle strength, aerobic endurance, and physical performance over 4 months of supplementation. Biomarkers associated with mitochondrial function and inflammation also improved. Long-term safety data remains limited.
References
- Durability DL, et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. ↗
- González-Sarrías A, et al. Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far. ↗
Related compounds
First mitochondria-derived peptide discovered, encoded from mitochondrial DNA. Demonstrates cytoprotective and anti-apoptotic properties with particular relevance for neurological health and longevity.
Nicotinamide adenine dinucleotide. Essential coenzyme for cellular energy production and DNA repair. Levels decline with age. Administered via injection to bypass digestive breakdown.
Mitochondria-targeted tetrapeptide that stabilizes cardiolipin in the inner mitochondrial membrane. Reduces oxidative stress and supports cellular energy production.